(Received for publication, August 4, 1962) The Administered anticancer agents were Mitomycin C, thio-TEPA, B-518, Chromomycin and Merphyrin. They were administered by routine method or intermittent massive dose technique pre-and postoperatively. Each dose of these drugs was given as follows:-40 mg. of Mitomycin C (2 mg. every day in routine method, 10 mg. every third day in intermittent massive dose method), 80 mg. of thio-TEPA (5 mg. every day in the former, 20 mg. every third day in the latter), 2 gm. of B-518 (200 mg. every day in the former, 500 mg. every third day in the latter), 10 mg. of Chromomycin (0.5 mg. every day) and 300 mg. of Merphyrin (25 mg. every third day). 
RESULTS
Of the 102 cases, the distribution of curative, subcurative, palliative resected and nonresectable cases were 19%, 25%, 23% and 33% respectively. At the time of admission to the hospital, 2 (11%) of 19 curative resected cases, 10 (38%) of 26 subcurative resected cases, 14 (61%) of palliative resected 23 cases and 24 (71%) of 34 nonresectable cases were positive with tumor cells in blood. 49% (50 cases) of 102 patients were positive with tumor cells in the blood at the time of admission to the hospital, and this recovery rate was increased to 66% with followed up observations including the regular visits after discharge. i.e. on curative resected group, all of 2 positive cases were changed to negative; on subcurative group, 7 (78%) of 9 positive cases; on nonresectable group, none of 20 positive cases.
There were five types of reaction of tumor cells in the blood by surgery.
Type I: After the operation the cancer cells in the blood disappeared during Concerning the behavior of tumor cells in the blood, a tendency similar to that produced by the operation was found by the administration of anticancer agents. As presented in Table V , the disappearance of tumor cells from the blood was observed in 9 (36%) of 25 cases administered with Mitomycin C, 2 (25%) of 8 cases with Merphyrin, 4 (45%) of 9 cases with thio-TEPA, 5 (42%) of 12 cases with B-518 and one of 4 cases with Chromomycin. But its duration was very short (from 2 weeks to 3 months). With regard to the method of administration of the agent, the percentage of disappearance of tumor cells in the blood was higher by the intermittent massive dose technique than by the routine method. DISCUSSION 
AND CONCLUSION
According to several3,7,8,9,10) reports, the discovery rate of tumor cells in peripheral blood ranges from 1.6 to 45.5% . According to our result, cancer cells in the blood were found 50 cases (49%) of 102 patients with cancer. Although the differences in technique of isolating cancer cells and standard of estimation of cancer cells might influence the positivity rate, our cases included so many advanced cases, that the total of positive cases would be counted numerous.
And it was found, that the recovery rate of cancer cells in the blood was parallel to the extent of cancerous lesions, in some measure.
In 1961, Watne11) and his co-workers reported, when they followed the palliative or curative resected cases up to 18 months after the surgery, patients with cancer cells in the blood survived 54% and patients without cancer cells in the blood survived 71%. On the contrary, Engell4) (1959) and Roberts12) (1960) found no differences in survival time between patients with and without cancer cells in the blood. With our result, some correlation could be established between the curability of operation and the incidence of cancer cells in the blood, namely, the appearance of cancer cells in the blood before the operation suggests that the patient's lesions were operatively noncurable at a high rate, and the appearance of cancer cells in the blood after the operation suggests that noncurative resection had been carried out. These facts were verified by the results, that in all cases in which cancer cells were found in the blood more than 3 weeks after operation, cancerous recurrence or death resulted within 8 months from the time of discovering cancer cells in the blood, and the survival rate of negative cases, at one year after the operation, was from 3 to 9 times larger than that of the positive cases.
And it may be said that tumor cells in cubital venous blood have a more serious influence upon the patient's prognosis than that in draining local blood.
Clinical reports5,8,10,13) on the effect of chemotherapy to cancer cells in the blood are very few, and a systemic observation could not be found. In 21 (36%) of our 58 cases, cancer cells in the blood disappeared by chemotherapy even though the term of disappearance was very short (from 2 weeks to 3 months) regardless of using the agents. The effect of a given anticancer agent may be justified by the disappearance of tumor cells from the blood. And the short term of disappearance of tumor cells suggests the clinical limit of the effect of the agent used in each case. 
